Despite the uncertainties in global macroeconomic activities, the top 20 global biopharmaceutical companies experienced a promising first quarter in 2024.
GlobalData recently reported that these companies' market capitalizations increased by 9.6% to reach $4 trillion.
As of March 31, 2024, seven companies reported positive growth in market capitalization, led by Lilly (33.7%), Novo Nordisk (23.8%), and Merck & Co (21%).
Top Biopharmaceutical Companies Report 9.6% Market Capitalization Growth
Pandemic Had Temporary Negative Effect on Breast Cancer Screening
However, prolonged negative effect was seen on follow-up screening